Currently rifaximin 200 mg three times a day for 3 days is the safest treatment and is equally as effective as systemic antibiotics against most cases of travelers' diarrhea. Absorbed drugs are ...

Rifaximin is a semi-synthetic derivative of rifampin and acts by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase blocking one of the steps in transcription. This results in ...

Lactulose 20 g orally twice daily and rifaximin 200 mg orally three times daily were started on day 5 for possible hepatic encephalopathy, even though the patient's ammonia levels were within ...

Roughly half as many patients with cirrhosis in remission from overt hepatic encephalopathy (OHE) experienced a breakthrough ...

For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer ...

The antibiotic, rifaximin, has enabled the global emergence of vancomycin-resistant enterococcus faecium, or VRE, a superbug that frequently causes serious infections in hospitalised patients ...

For patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement, rifaximin used before and after the procedure is associated with a reduced risk for overt ...

Australian research has found that the widespread use of the antibiotic rifaximin is fueling the rise of a nearly untreatable superbug. (1 Trusted Source In a study published, international ...

All subjects underwent lactulose/methane breath test (LBT) to assess SIBO before and one month after the treatment with Rifaximin 600 mg daily. All IBS pts filled out a Visual Analogic Scale (VAS ...

The antibiotic, rifaximin, has enabled the global emergence of vancomycin-resistant enterococcus faecium, or VRE, a superbug ...

Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy. HealthDay News — For patients with a history of overt hepatic ...